Efficient DNA-mediated gene transfer into prostate cancer cell line LNCaP

Prostate

Volumn 43, Issue 2, 2000, Pages 111-117

  Frønsdal, Katrine ^a   Engedal, Nikolai ^a   Saatcioglu, Fahri ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Gene expression; LNCaP cells; Prostate cancer; Transcription; Transfection methods

Indexed keywords

ARTICLE; CANCER CELL CULTURE; CANCER MODEL; CARCINOGENESIS; CELL STRUCTURE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; TECHNIQUE;

DNA; GENE TRANSFER TECHNIQUES; GENETIC TECHNIQUES; HUMANS; MALE; PROSTATIC NEOPLASMS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033994738     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(20000501)43:2<111::AID-PROS5>3.0.CO;2-4     Document Type: Article

References (17)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer Statistics 1997. CA Cancer J Clin 1997;47:5-27.
2. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin 1999;49:8-31.
3. Huggins C, Hodges CV. The effects of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1941;1:293-297.
4. Isaacs J. Role of androgens in prostatic cancer. Vitam Horm 1994;49:433-502.
5. Coffey DS. Prostate cancer: an overview of an increasing dilemma. Cancer 1992;71:880-886.
6. Horoszewicz JS, Leong SS, Chu TM, Wajsman ZL, Friedman M, Papsidero L, Kim U, Chai LS, Kakati S, Arya SK, Sandberg AA. The LNCaP cell line - a new model for studies on human prostatic carcinoma. Prog Clin Biol Res 1980;37:115-132.
7. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA, Murphy GP. LNCaP model of human prostatic carcinoma. Cancer Res 1983;43:1809-1818.
8. Klein KA, Reiter RE, Redula J, Moradi H, Zhu XL, Brothman AR, Lamb DJ, Marcelli M, Belldegrun A, Witte ON, Sawyers CL. Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice. Nat Med 1997;3: 402-408.
9. Horoszewicz JS, Kawinski E, Murphy GP. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. Anticancer Res 1987;7:927-935.
10. Henttu P, Liao SS, Vihko P. Androgens up-regulate the human prostate-specific antigen messenger ribonucleic acid (mRNA), but down-regulate the prostatic acid phosphatase mRNA in the LNCaP cell line. Endocrinology 1992;130:766-772.
11. Young CY, Andrews PE, Tindall DJ. Tissue-specific and hormonal regulation of human prostate-specific glandular kallikrein. Biochemistry 1992;31:818-824.
12. Gleave ME, Hsieh JT, Wu HC, von Eschenbach AC, Chung LW. Serum prostate specific antigen levels in mice bearing human prostate LNCaP tumors are determined by tumor volume and endocrine and growth factors. Cancer Res 1992;52:1598-1605.
13. Ruokonen M, Shan JD, Hedberg P, Patrikainen L, Vihko P. Transfecting well-differentiated prostatic cancer cell line LNCaP. Biochem Biophys Res Commun 1996;218:794-796.
14. Graham FL, van der Eb AJ. A new technique for the assay of infectivity of human adenovirus 5DNA. Virology 1973;52:546.
15. Ausebel FM, Brent R, Kingston R, Moore DD, Seidman JG, Smith JA, Struhl K, editors. Current protocols in molecular biology. New York: John Wiley and Sons; 1997.
16. Boussif O, Lezoualc'h F, Zanta MA, Mergny MD, Scherman D, Demeneix B, Behr JP. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA 1996;92:7297-7301.
17. Palvimo JJ, Reinikainen P, Ikonen T, Kallio PJ, Moilanen A, Janne OA. Mutual transcriptional interference between RelA and androgen receptor. J Biol Chem 1996;271:24151-24156.